Showing results (1471-1480 of 1,592) with videos related to

Sort By:
Pageof 160
Pain Practice : the Official Journal of World Institute of Pain|April 23, 2025
Paddle leads for the treatment of nonsurgical back pain-The DISTINCT studySteven Falowski, Michael J Dorsi, Robert Heros, et al.
Thyroid : Official Journal of the American Thyroid Association|August 19, 2025
Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in RET-Mutant Medullary Thyroid CancerRossella Elisei, Lori J Wirth, Jaume Capdevila, et al.
Journal for Immunotherapy of Cancer|October 25, 2023
PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesotheliomaKrisztian Homicsko, Panagiota Zygoura, Maxim Norkin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2022
Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancerD Gale, K Heider, A Ruiz-Valdepenas, et al.
Targeted Oncology|September 30, 2018
Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial CarcinomaAlice Tzeng, C Marcela Diaz-Montero, Patricia A Rayman, et al.
Irish Medical Journal|December 7, 2018
The Doctor Can See You Now: A Key Stakeholder Study Into The Acceptability Of Ambulance Based TelemedicineP Gilligan, A Bennett, A Houlihan, et al.
JCI Insight|February 13, 2019
A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamicsMichael W O'Reilly, Connar Sj Westgate, Catherine Hornby, et al.
Targeted Oncology|March 25, 2020
Blood Myeloid-Derived Suppressor Cells Correlate with Neutrophil-to-Lymphocyte Ratio and Overall Survival in Metastatic Urothelial CarcinomaIris Y Sheng, Claudia Marcela Diaz-Montero, Patricia Rayman, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 17, 2021
Neutrophil-Lymphocyte Ratio and Absolute Lymphocyte Count as Prognostic Markers in Patients Treated with Curative-intent Radiotherapy for Non-small Cell Lung CancerA Punjabi, E Barrett, A Cheng, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 30, 2025
Defining the Clinical Target Volume in Postoperative Thymic Epithelial Tumours - A Clinical Practice Guide for UK Clinical OncologistsS D Robinson, P Bhatnagar, R Duerden, et al.
Pageof 160